# Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies

> clinical trial · VERIFIED · 2026-07-13

Status: RECRUITING · Sponsor: Lakefront Biotherapeutics NV · Condition: Hematological Malignancies

- Company: Lakefront Biotherapeutics NV
- Sector: Hematological Malignancies
- Primary source: https://clinicaltrials.gov/study/NCT06652633

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.